Avant Genomics
AG
AV

Avant Genomics

Agent38Agent Readiness: 38/100. Below median. Measured by StartupHub.ai. Median 41.Speed79Site Speed: 79/100. Top 25%. Measured by Google PageSpeed. Median 62.

Developing an automated platform for liquid biopsy sample preparation.

Website
2021InactiveCharlottesville, USA

About

Avant Genomics is a startup focused on advancing the development of the Avant Source™, an automated platform designed for liquid biopsy sample preparation. This platform aims to streamline and improve the process of preparing samples for liquid biopsies, which are crucial for non-invasive disease detection and monitoring.

Key facts

At-a-glance profile data

Website
avantgenomics.com
Headquarters
Charlottesville, Virginia, USA
Founded
2021
Total funding
$3M (Funding Round)
Business model
B2B

Funding rounds

Funding rounds raised by Avant Genomics
DateRoundAmountLead investors
13 May 2026Funding Round$3M-

Tech stack

Detected on avantgenomics.com, last scanned 15 Jun 2026. Run your own scan

Email provider
Microsoft 365
Add first review

Frequently asked

How much funding has Avant Genomics raised?

Avant Genomics has raised a total of $3M in funding. The most recent round on record is Funding Round.

What is Avant Genomics's current status?

Avant Genomics's current operating status is: Inactive.